Explain this page
Arphra AIPlain-English read on Eli Lilly and Company’s valuationCompany profile
DB · companies + sec_company_profile + company_profilesEli Lilly and Company (LLY) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolLLY
- Legal nameEli Lilly and Company
- CEO—
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CountryUS
- CurrencyUSD
- ExchangeNYSE
- IPO date—
- CIK0000059478
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$910.17B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge market-data, SEC, and non-US sources.
- FIGIBBG000BNBDC2
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| David A. Ricks | Chairman & CEO | $8.92M | 1968 | — |
| Daniel Skovronsky | Chief Scientific & Product Officer and President of Lilly Research Laboratories | $4.9M | 1974 | — |
| Anat Hakim | Executive Vice President, General Counsel & Secretary | $3.34M | 1969 | — |
| Lucas E. Montarce | Executive Vice President & Chief Financial Officer | $3.24M | 1978 | — |
| Jacob S. Van Naarden | Executive VP, President of Lilly Oncology & Head of Corporate Business Development | $3M | 1985 | — |
| Patrik Jonsson | Executive VP & President of Lilly International | $1.67M | 1967 | — |
| Gordon Brooks | Group Vice President, Controller & Corporate Strategy | $1.31M | — | — |
| Diogo Rau | Executive VP and Chief Information & Digital Officer | $1.06M | 1975 | — |